• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌与益生元:在临床疾病状态中的作用

Probiotics and prebiotics: role in clinical disease states.

作者信息

Chen Chien-Chang, Walker W Allan

机构信息

Chang Gung University and Chang Gung Children's Hospital, Taoyuan, Taiwan.

出版信息

Adv Pediatr. 2005;52:77-113. doi: 10.1016/j.yapd.2005.03.001.

DOI:10.1016/j.yapd.2005.03.001
PMID:16124337
Abstract

Parents of pediatric patients are seeking alternatives to conventional therapy in the prevention and treatment of gastrointestinal disease states because of therapeutic failures caused by the increased incidence of antibiotic resistance. One such alternative is the use of probiotics and prebiotics to stimulate health-promoting indigenous flora to affect pathogen colonization and expression of disease. Probiotics are live flora given in oral quantities that allow for colonization of the colon. Probiotics are given as functional foods or dietary supplements, and function to activate the mucosal immune system and prevent pathogen colonization and translocation by strengthening the mucosal barrier, interfering with pathogen colonization, and in some instances, producing secretory antibacterial substances. Prebiotics are nondigestible carbohydrates, principally oligosoccharides, that are fermented by colonic commensals, stimulating their proliferation and producing short-chain fatty acids. Both protective nutrients have been shown to reduce the incidence and severity of infantile diarrhea, particularly rotaviral gastroenteritis, prevent antibiotic-induced diarrhea, and prevent and treat intestinal food allergy. With additional multicenter clinical trial confirmations, these substances may become routine in the care of infants and young children.

摘要

由于抗生素耐药性增加导致治疗失败,儿科患者的家长正在寻求传统疗法之外的方法来预防和治疗胃肠道疾病。其中一种替代方法是使用益生菌和益生元来刺激促进健康的本土菌群,以影响病原体的定植和疾病的表现。益生菌是口服的活菌群,可在结肠定植。益生菌作为功能性食品或膳食补充剂服用,其功能是激活黏膜免疫系统,并通过加强黏膜屏障、干扰病原体定植以及在某些情况下产生分泌性抗菌物质来防止病原体定植和易位。益生元是不可消化的碳水化合物,主要是低聚糖,可被结肠共生菌发酵,刺激它们的增殖并产生短链脂肪酸。这两种保护性营养素都已被证明可降低婴儿腹泻(尤其是轮状病毒性肠胃炎)的发病率和严重程度,预防抗生素引起的腹泻,以及预防和治疗肠道食物过敏。随着更多多中心临床试验的证实,这些物质可能会成为婴幼儿护理中的常规用药。

相似文献

1
Probiotics and prebiotics: role in clinical disease states.益生菌与益生元:在临床疾病状态中的作用
Adv Pediatr. 2005;52:77-113. doi: 10.1016/j.yapd.2005.03.001.
2
The role of gut-associated lymphoid tissues and mucosal defence.肠道相关淋巴组织及黏膜防御的作用。
Br J Nutr. 2005 Apr;93 Suppl 1:S41-8. doi: 10.1079/bjn20041356.
3
Probiotics and prebiotics in prevention and treatment of diseases in infants and children.益生菌和益生元在婴幼儿疾病防治中的应用。
J Pediatr (Rio J). 2011 Jul-Aug;87(4):292-300. doi: 10.2223/JPED.2103. Epub 2011 Jul 8.
4
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.人类结肠微生物群的饮食调节:引入益生元的概念。
J Nutr. 1995 Jun;125(6):1401-12. doi: 10.1093/jn/125.6.1401.
5
Probiotics and prebiotics in pediatrics.儿科中的益生菌和益生元。
Pediatrics. 2010 Dec;126(6):1217-31. doi: 10.1542/peds.2010-2548. Epub 2010 Nov 29.
6
Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children.《细菌与肠道:益生菌在儿童胃肠道疾病中的实际应用》
Nutr Clin Pract. 2015 Dec;30(6):747-59. doi: 10.1177/0884533615610081.
7
Prebiotics and lipid metabolism.益生元与脂质代谢。
Curr Opin Lipidol. 2002 Feb;13(1):61-7. doi: 10.1097/00041433-200202000-00009.
8
How to Manipulate the Microbiota: Prebiotics.如何调控微生物群:益生元。
Adv Exp Med Biol. 2016;902:119-42. doi: 10.1007/978-3-319-31248-4_9.
9
[Prebiotics and probiotics in infant nutrition].[婴儿营养中的益生元与益生菌]
Pediatr Med Chir. 2007 Mar-Apr;29(2):69-83.
10
Probiotics and prebiotics: A brief overview.益生菌与益生元:简要概述。
J Ren Nutr. 2002 Apr;12(2):76-86. doi: 10.1053/jren.2002.31759.

引用本文的文献

1
Characterization of Vaginal Lactobacilli with Potential Probiotic Properties Isolated from Healthy Women in Northern Iran.从伊朗北部健康女性中分离出的具有潜在益生菌特性的阴道乳酸杆菌的特性研究
Indian J Microbiol. 2024 Jun;64(2):529-539. doi: 10.1007/s12088-023-01186-2. Epub 2024 Apr 4.
2
A droplet-based microfluidic approach to isolating functional bacteria from gut microbiota.基于液滴的微流控方法从肠道微生物群中分离功能细菌。
Front Cell Infect Microbiol. 2022 Aug 18;12:920986. doi: 10.3389/fcimb.2022.920986. eCollection 2022.
3
Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.
n-3 多不饱和脂肪酸的肠内营养调控作用可调节小鼠的微生物组和脂质代谢。
PLoS One. 2021 Mar 25;16(3):e0248482. doi: 10.1371/journal.pone.0248482. eCollection 2021.
4
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development.肠道屏障功能障碍、内毒素移位与疾病发展。
J Endocr Soc. 2020 Feb 20;4(2):bvz039. doi: 10.1210/jendso/bvz039. eCollection 2020 Feb 1.
5
Chemical Profile, Antioxidative, and Gut Microbiota Modulatory Properties of Ganpu Tea: A Derivative of Pu-erh Tea.甘普茶的化学成分、抗氧化及调节肠道微生物群特性:一种普洱茶的衍生品。
Nutrients. 2020 Jan 15;12(1):224. doi: 10.3390/nu12010224.
6
Fighting AMR in the Healthcare Environment: Microbiome-Based Sanitation Approaches and Monitoring Tools.在医疗环境中对抗 AMR:基于微生物组的卫生方法和监测工具。
Int J Mol Sci. 2019 Mar 27;20(7):1535. doi: 10.3390/ijms20071535.
7
Fructooligosaccharide raftilose reduces the mycophenolate mofetil-induced complications: Hematological and biochemical alterations.低聚果糖(菊粉型果聚糖)可降低霉酚酸酯引起的并发症:血液学和生化改变。
Vet Res Forum. 2015 Fall;6(4):319-26. Epub 2015 Dec 15.
8
Isolation and Characterization of Putative Probiotic Bacterial Strain, Bacillus amyloliquefaciens, from North East Himalayan Soil Based on In Vitro and In Vivo Functional Properties.基于体外和体内功能特性从喜马拉雅东北部土壤中分离和鉴定假定的益生菌菌株解淀粉芽孢杆菌
Probiotics Antimicrob Proteins. 2011 Dec;3(3-4):175-85. doi: 10.1007/s12602-011-9081-8.
9
Gut microbiota as potential orchestrators of irritable bowel syndrome.肠道微生物群作为肠易激综合征的潜在调节者
Gut Liver. 2015 May 23;9(3):318-31. doi: 10.5009/gnl14344.
10
The use of prebiotics during the first year of life for atopy prevention and treatment.在生命的第一年使用益生元预防和治疗特应性皮炎。
Immun Inflamm Dis. 2013 Oct;1(1):63-9. doi: 10.1002/iid3.8. Epub 2013 Oct 30.